Springowl Associates’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-9,647
Closed -$341K 22
2015
Q3
$341K Buy
9,647
+4,100
+74% +$185K 1.21% 23
2015
Q2
$331K Buy
+5,547
New +$373K 1.2% 20

Other funds holding HHS

Springowl Associates's HHS Position: Q4 2015 in Review

Springowl Associates sold out of Harte-Hanks (HHS) in Q4 2015, closing a stake of 9,647 shares — an estimated $341K sold.

Springowl Associates first reported a position in HHS in Q2 2015 and held it in 2 quarters. The position peaked at $341K in Q3 2015. 124 funds tracked by Wall St. Rank hold HHS as of Q4 2015.

  • Springowl Associates reported no remaining Harte-Hanks position as of Q4 2015 after selling out during the quarter.
  • Springowl Associates sold 9,647 Harte-Hanks shares in Q4 2015, an estimated $341K.
  • Springowl Associates first reported a position in Harte-Hanks in Q2 2015 and held it in 2 quarters.
  • Springowl Associates's Harte-Hanks position peaked at $341K in Q3 2015.
  • 124 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2015.

Based on Springowl Associates's 13F filing for Q4 2015, filed 16 Feb 2016.